Anda belum login :: 23 Nov 2024 14:35 WIB
Detail
BukuAnalisis Return On Assets (ROA), Economic Value Added (EVA) Dan Financial Value Added (FVA) Terhadap Return Saham Tndustri Farmasi Pada Bursa Efek Indonesia Tahun 2012
Bibliografi
Author: INTARTO, YERRI ; PRASETIO, SATRIO (Advisor)
Topik: Return on Assets. Economic Value Added. Financial Value Added. Stock Return
Bahasa: (ID )    
Penerbit: Program Studi Magister Manajemen Sekolah Pascasarjana Universitas Katolik Indonesia Atma Jaya     Tempat Terbit: Jakarta    Tahun Terbit: 2013    
Jenis: Theses - Master Thesis
Fulltext:
Ketersediaan
  • Perpustakaan Pusat (Semanggi)
    • Nomor Panggil: MM-698
    • Non-tandon: tidak ada
    • Tandon: 1
 Lihat Detail Induk
Abstract
The objective of this research to examine the value of ROA. EVA, and FVA of the pharmaceutical industry company listed on ike Indonesia Stock Exchange in 2012, i.e. FT Darya-Varia Laboratoria Tbk (DVLA), PT Indofarma Tbk (INAF). PTKalbe Forma Tbk (KLBF), PT Kimia Farma Tbk (KAEF), PT Merck Indonesia Tbk (MERK), PT Pyridam Farma Tbk (PYFA), as well as to determine the value of pharmaceutical industry slock returns listed on the Indonesia Stock Exchange in 2012.

The data collected in this study by taking half and annual of the financial statements audited companies {Audited Annual Report) in 2012 m fhe Indonesian Stock Exchange (Indonesian Capital Market Electronic Library) To rest these variables, the authors use stock price data of 2012 and financial statement data pharmaceutical industry company Hsfed on the Indonesia Stock Exchange in 2012
The results showed that of the result of the calculation is performed to find the value of ROA, EVA. and FVA in the pharmaceutical industry has a positive influence on stock returns.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Lihat Sejarah Pengadaan  Konversi Metadata   Kembali
design
 
Process time: 0.15625 second(s)